PHARMACOKINETIC AND PHARMACODYNAMIC TRIALS FOR MEDICATION DEVELOPMENT IN SUD. TO1 PHASE 1 COCAINE DRUG INTERACTION SEPTEMBER 25, 2023 TO MARCH 24, 2025. N01DA-23-893
$1,838,615N01FY2023DANIH
Investigators
Abstract
Pharmacokinetic and Pharmacodynamic Trials for Medication Development in SUD
View original record on NIH RePORTER →